Shanghai Qingsai Biotechnology Co., Ltd.
PrivateLast Round
Series A
Apr 3, 2024
Total Funding Raised
$13.89M
Company Overview
Shanghai Qingsai Biotechnology Co., Ltd. is a biopharmaceutical company that focuses on the research, development, and production of innovative and safe vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Qingsai Biotechnology Co., Ltd. Comparables
Compare Shanghai Qingsai Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Saierfusen Biotechnology Co., Ltd. | 83% | |
| BravoVax Co., Ltd. | 78% | |
| Siwei Biotechnology | 76% |
Shanghai Qingsai Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 3, 2024 |
Shanghai Qingsai Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Haitong Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2024
$14M round led by Haitong Capital and Tasly Pharmaceutical Group.
Shanghai Qingsai Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Qingsai Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Qingsai Biotechnology Co., Ltd. a public or private company?
Shanghai Qingsai Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shanghai Qingsai Biotechnology Co., Ltd.?
Shanghai Qingsai Biotechnology Co., Ltd. is a private company with no public stock price. Caplight tracks Shanghai Qingsai Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Shanghai Qingsai Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Shanghai Qingsai Biotechnology Co., Ltd. is not publicly available.
Can I buy Shanghai Qingsai Biotechnology Co., Ltd. stock?
Shanghai Qingsai Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Qingsai Biotechnology Co., Ltd.'s last funding round?
Shanghai Qingsai Biotechnology Co., Ltd.'s most recent funding round was Series A on April 3, 2024.
Who are the main investors in Shanghai Qingsai Biotechnology Co., Ltd.?
Key investors in Shanghai Qingsai Biotechnology Co., Ltd. include Haitong Capital.
Will Shanghai Qingsai Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Qingsai Biotechnology Co., Ltd..
How can I track Shanghai Qingsai Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Qingsai Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.